Prevention and Early Detection

Early detection increases a man’s chances for a cure, making treatment easier and/or improving his quality of life.

Primarily focusing on the:
•     Discovery and evaluation of novel biomarkers as readouts of prostate cancer detection and
      patient risk profile stratification.
•     Development of clinically significant biomarker studies to evaluate current prostate cancer
      therapeutic treatments.

There is also a need to better understand the role of genetics, diet, hormones and lifestyle as risk factors for
prostate cancer.